Hillsdale Investment Management’s Phibro Animal Health PAHC Stock Holding History

Hillsdale Investment Management’s Portfolio PAHC Stock Details PAHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$415K	Buy	7,500 +7,280	+3,309%	+$347K	0.01%	433
2025 Q4	$8.22K	Sell	220 -30	-12%	-$1.22K	﹤0.01%	596
2025 Q3	$10.1K	Sell	250 -80	-24%	-$2.64K	﹤0.01%	545
2025 Q2	$8.43K	Hold	330	–	–	﹤0.01%	529
2025 Q1	$7.05K	Buy	330 +30	+10%	+$670	﹤0.01%	510
2024 Q4	$6.3K	Buy	+300	New	+$6.94K	﹤0.01%	552
2022 Q4	–	Sell	-246,400	Closed	-$3.27M	–	605
2022 Q3	$3.27M	Hold	246,400	–	–	0.3%	132
2022 Q2	$4.71M	Buy	+246,400	New	+$4.67M	0.38%	90
2020 Q4	–	Sell	-86,800	Closed	-$1.51M	–	643
2020 Q3	$1.51M	Hold	86,800	–	–	0.15%	161
2020 Q2	$2.28M	Buy	+86,800	New	+$2.16M	0.21%	148
2019 Q2	–	Sell	-48,500	Closed	-$1.6M	–	661
2019 Q1	$1.6M	Hold	48,500	–	–	0.15%	140
2018 Q4	$1.56M	Buy	48,500 +13,000	+37%	+$490K	0.19%	132
2018 Q3	$1.52M	Hold	35,500	–	–	0.2%	105
2018 Q2	$1.64M	Hold	35,500	–	–	0.2%	84
2018 Q1	$1.41M	Hold	35,500	–	–	0.2%	79
2017 Q4	$1.19M	Hold	35,500	–	–	0.19%	137
2017 Q3	$1.31M	Buy	35,500 +1,000	+3%	+$37.6K	0.22%	81
2017 Q2	$1.28M	Hold	34,500	–	–	0.25%	67
2017 Q1	$969K	Buy	+34,500	New	+$973K	0.19%	116

Other funds holding PAHC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Hillsdale Investment Management's PAHC Position: Q1 2026 in Review

Hillsdale Investment Management increased its Phibro Animal Health (PAHC) stake by 3,309% in Q1 2026, buying an estimated $347K and bringing the position to 7,500 shares worth $415K. The position accounts for 0.01% of the portfolio, ranked #433.

Hillsdale Investment Management first reported a position in PAHC in Q1 2017 and has held it in 19 quarters since. The position peaked at $4.71M in Q2 2022. 257 funds tracked by Wall St. Rank hold PAHC as of Q1 2026.

Hillsdale Investment Management held 7,500 shares of Phibro Animal Health worth $415K as of Q1 2026.
Hillsdale Investment Management bought 7,280 Phibro Animal Health shares in Q1 2026, an estimated $347K.
Phibro Animal Health made up 0.01% of Hillsdale Investment Management's portfolio in Q1 2026, its #433 holding.
Hillsdale Investment Management first reported a position in Phibro Animal Health in Q1 2017 and has held it in 19 quarters since.
Hillsdale Investment Management's Phibro Animal Health position peaked at $4.71M in Q2 2022.
257 funds tracked by Wall St. Rank held Phibro Animal Health as of Q1 2026.

Based on Hillsdale Investment Management's 13F filing for Q1 2026, filed 4 May 2026.